High Affinity CD16 Polymorphism Associated with Reduced Risk of Severe COVID-19.
Anita E Qualls,Tasha Tsao, Irene Lui, Shion A Lim,Yapeng Su, Ernie Chen, Dylan Duchen, Holden T Maecker,Seunghee Kim-Schulze, Ruth R Montgomery,Florian Krammer, Charles R Langelier,Ofer Levy,Lindsey R Baden,Esther Melamed, Lauren Ir Ehrlich, Grace A McComsey, Rafick P Sekaly,Charles B Cairns,Elias K Haddad, Albert C Shaw,David A Hafler,David B Corry,Farrah Kheradmand,Mark A Atkinson,Scott C Brakenridge,Nelson I Agudelo Higuita,Jordan P Metcalf, Catherine L Hough,William B Messer,Bali Pulendran,Kari C Nadeau, Mark M Davis, Ana Fernandez-Sesma, Viviana Simon,Monica Kraft,Christian Bime, Carolyn S Calfee,David J Erle, Joanna Schaenmann, Al Ozonoff,Bjoern Peters, Steven H Kleinstein,Alison D Augustine,Joann Diray-Arce,Patrice M Becker,Nadine Rouphael, Impacc Network,Jason D Goldman,Daniel R Calabrese,James R Heath, James A Wells, Elaine F Reed, Lewis L Lanier,Harry Pickering, Oscar A Aguilar JCI insight（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper